| $381M | ||
| $350M | ||
| $215M | ||
| $107M | ||
| $100M | ||
| $91M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Aethlon Medical, Inc. operates as a medical technology enterprise, dedicated to innovating solutions for the diagnosis and treatment of life-threatening and organ-jeopardizing diseases within the United States. Central to its pipeline is the Aethlon Hemopurifier, a clinical-stage immunotherapeutic device. This device is engineered to clear the human circulatory system of detrimental tumor-derived exosomes and perilous viruses. Notably, this capability extends to targeting the COVID-19 virus, its various strains, and associated exosomes. Furthermore, Aethlon Medical maintains a collaborative partnership with the University of Pittsburgh Medical Center's Hillman Cancer Center, conducting studies pertinent to head and neck cancer. Established in 1999, the company is headquartered in San Diego, California.
Over the last 12 months, insiders at Aethlon Medical, Inc. have bought $0 and sold $0 worth of Aethlon Medical, Inc. stock.
On average, over the past 5 years, insiders at Aethlon Medical, Inc. have bought $0 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
| 2020-12-17 | Sale | Shah Chetan | director | 26,852 0.2008% | $2.11 | $56,580 | +15.02% | |
| 2010-04-13 | Sale | BROENNIMAN EDWARD G | director | 9,800 0.015% | $0.34 | $3,283 | -50.00% | |
| 2010-04-12 | Sale | BROENNIMAN EDWARD G | director | 25,000 0.0383% | $0.34 | $8,375 | -50.00% | |
| 2010-04-09 | Sale | BROENNIMAN EDWARD G | director | 25,000 0.0381% | $0.33 | $8,338 | -50.00% | |
| 2010-04-08 | Sale | BROENNIMAN EDWARD G | director | 25,000 0.0383% | $0.34 | $8,375 | -50.00% | |
| 2010-04-07 | Sale | BROENNIMAN EDWARD G | director | 24,000 0.0395% | $0.35 | $8,400 | -48.48% | |
| 2010-04-07 | Sale | BARRY FRANKLYN S JR | director | 8,800 0.0145% | $0.35 | $3,080 | -48.48% | |
| 2010-04-06 | Sale | BROENNIMAN EDWARD G | director | 23,800 0.0359% | $0.35 | $8,330 | -52.78% | |
| 2010-04-06 | Sale | BARRY FRANKLYN S JR | director | 23,800 0.0359% | $0.35 | $8,330 | -52.78% | |
| 2010-04-05 | Sale | BROENNIMAN EDWARD G | director | 23,000 0.0348% | $0.35 | $8,073 | -52.78% | |
| 2010-04-05 | Sale | BARRY FRANKLYN S JR | director | 23,000 0.0348% | $0.35 | $8,073 | -52.78% | |
| 2010-04-01 | Sale | BROENNIMAN EDWARD G | director | 22,800 0.0354% | $0.37 | $8,436 | -54.05% | |
| 2010-04-01 | Sale | BARRY FRANKLYN S JR | director | 22,800 0.0354% | $0.37 | $8,436 | -54.05% | |
| 2010-03-31 | Sale | BROENNIMAN EDWARD G | director | 22,000 0.0328% | $0.36 | $8,030 | -55.26% | |
| 2010-03-31 | Sale | BARRY FRANKLYN S JR | director | 22,000 0.033% | $0.37 | $8,074 | -55.26% | |
| 2010-03-30 | Sale | BROENNIMAN EDWARD G | director | 22,000 0.041% | $0.38 | $8,360 | -51.39% | |
| 2010-03-30 | Sale | BARRY FRANKLYN S JR | director | 22,000 0.0404% | $0.37 | $8,239 | -51.39% | |
| 2010-03-29 | Sale | BROENNIMAN EDWARD G | director | 22,000 0.0384% | $0.39 | $8,470 | -55.13% | |
| 2010-03-29 | Sale | BARRY FRANKLYN S JR | director | 22,000 0.0377% | $0.38 | $8,327 | -55.13% | |
| 2010-03-26 | Sale | BROENNIMAN EDWARD G | director | 20,000 0.0362% | $0.41 | $8,200 | -56.25% |
| Increased Positions | 4 | +13.79% | 2,052 | +3.94% |
| Decreased Positions | 14 | -48.28% | 37,675 | -72.31% |
| New Positions | <1 | New | <1 | New |
| Sold Out Positions | 11 | Sold Out | 36,459 | Sold Out |
| Total Postitions | 19 | -34.48% | 16,478 | -68.37% |
| Ikarian Capital, Llc | $43.00 | 1.54% | 15,366 | 0 | 0% | 2025-09-30 |
| Hrt Financial Lp | $37.00 | 1.31% | 13,060 | +13,060 | New | 2025-09-30 |
| Citadel Advisors Llc | $27.00 | 0.95% | 9,508 | +9,508 | New | 2025-09-30 |
| Renaissance Technologies Llc | $13.00 | 0.46% | 4,600 | +4,600 | New | 2025-09-30 |
| Scientech Research Llc | $7.00 | 0.26% | 2,599 | +2,599 | New | 2025-09-30 |
| Two Sigma Investments, Lp | $6.00 | 0.2% | 2,027 | +2,027 | New | 2025-09-30 |
| Xtx Topco Ltd | $4.00 | 0.16% | 1,549 | +1,549 | New | 2025-09-30 |
| Two Sigma Securities, Llc | $4.00 | 0.15% | 1,468 | +1,468 | New | 2025-09-30 |
| Geode Capital Management, Llc | $4.00 | 0.14% | 1,347 | 0 | 0% | 2025-09-30 |
| Tower Research Capital Llc (Trc) | $1.00 | 0.03% | 299 | +228 | +321.13% | 2025-09-30 |